RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $800,767 | -27.8% | 95,216 | +7.9% | 0.00% | – |
| Q2 2023 | $1,108,520 | -35.5% | 88,258 | -15.5% | 0.00% | -100.0% |
| Q1 2023 | $1,719,419 | +36.1% | 104,397 | +23.6% | 0.00% | – |
| Q4 2022 | $1,263,000 | -33.8% | 84,477 | -0.9% | 0.00% | -100.0% |
| Q3 2022 | $1,908,000 | +33.9% | 85,283 | +0.3% | 0.00% | – |
| Q2 2022 | $1,425,000 | -34.8% | 85,056 | +16.4% | 0.00% | -100.0% |
| Q1 2022 | $2,186,000 | +9.7% | 73,054 | +12.6% | 0.00% | 0.0% |
| Q4 2021 | $1,993,000 | +46.4% | 64,898 | +50.3% | 0.00% | – |
| Q3 2021 | $1,361,000 | -6.0% | 43,175 | +9.1% | 0.00% | – |
| Q2 2021 | $1,448,000 | +15.1% | 39,591 | +8.8% | 0.00% | – |
| Q1 2021 | $1,258,000 | -31.7% | 36,386 | -17.9% | 0.00% | -100.0% |
| Q4 2020 | $1,841,000 | -5.7% | 44,313 | -3.3% | 0.00% | 0.0% |
| Q3 2020 | $1,953,000 | – | 45,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |